XXII

22nd Century Group, Inc. is a tobacco products company that enables cigarette smokers to take control of their consumption of nicotine, the addictive drug in cigarettes. The Company manufactures and distributes combustible tobacco products containing minimally or non-addictive levels of nicotine. Additionally, the Company provides turnkey contract manufacturing of cigarettes and filtered cigars for other established tobacco brands. The Company's product, VLN cigarette has 95% less nicotine than the traditional cigarette. The Company operates through a single segment named Tobacco. It is engaged in contract manufacturing organization (CMO) customer contracts that consist of obligations to manufacture the customers' branded filtered cigars and cigarettes. It is also engaged in the sale of its proprietary low nicotine content cigarettes, sold under the brand name VLN, or research cigarettes sold under the brand name SPECTRUM.

Wall Street analysts forecast XXII stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for XXII is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

22nd Century Group Inc revenue for the last quarter amounts to 2.28M USD, decreased -26.23 % YoY.

22nd Century Group Inc. EPS for the last quarter amounts to -2.50 USD, decreased -99.37 % YoY.

22nd Century Group Inc (XXII) has 56 emplpoyees as of December 16 2025.

Today XXII has the market capitalization of 6.51M USD.